why choose us

Clinical Trials Search

Showing 19,400 of 132,963 result(s)
Identification of Surrogate Blood and;or Urine Biomarker for Immulina TM (Trademark) in Normal Humans

Status: Completed

Condition: Adherence, Patient

Interventions: Immulina is a highly standardized extract derived from various preparations of Spirulina, a cyanobacterium, marketed as a dietary supplement and has b

Date: 2022-09-22

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Status: NOT_YET_RECRUITING

Condition: Glioma

Interventions: 18F-Fluciclovine will be injected via IV prior to PET-MRI imaging

Date: 2022-09-22

Pilot Testing Decision Making in Aging and Dementia for Autonomy Program in Nursing Homes

Status: Completed

Condition: Dementia

Interventions: DIGNITY is a multi-component, multi-level intervention that guides shared decision-making in nursing homes to support person-centered dementia care.

Date: 2022-09-22

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

Status: Completed

Condition: Metastatic Malignant Solid Neoplasm

Interventions: Undergo biopsy

Date: 2022-09-22

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

Status: Completed

Condition: COPD (Chronic Obstructive Pulmonary Disease)

Interventions: COPD Wellness consists of 10 weekly sessions led by the COPD Wellness Coach.
The intervention was designed to be portable, rely on little equipme

Date: 2022-09-22

eVusheld Assessment reaL wORld Effectiveness in the VA Health System

Status: Completed

Condition: SARS-CoV-2, COVID-19

Interventions: EVUSHELD users

Date: 2022-09-22

Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL

Status: Completed

Condition: Anal High Grade Squamous Intraepithelial Lesion

Interventions: artesunate formulated as intra-anal suppositories

Date: 2022-09-22

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Status: Completed

Condition: Metastatic Non Small Cell Lung Cancer

Interventions: Dato-DXd will be administered as an intravenous (IV) infusion every 3 weeks on Day 1 of each 21-day cycle.

Date: 2022-09-22

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

Status: Completed

Condition: High-grade Glioma

Interventions: Participants will be administered low doses of oral OKN-007 two times a day daily in 28-day cycles.

Date: 2022-09-22